To evaluate effect of Cutisora Oil and Cutisora Tablet in patients of Psoriasis.
Phase 2
Completed
- Conditions
- Health Condition 1: null- Suffering from mild to moderate psoriasis
- Registration Number
- CTRI/2017/09/009908
- Lead Sponsor
- Vasu Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 75
Inclusion Criteria
Mild to moderate psoriasis
Psoriasis area and severity index of less than 20
Clinical chemistry and hematology results from visit 1 are within normal limits.
Non pregnant female and must agree to use adequate method of contraception during the study.
Exclusion Criteria
Age less than 18 years and not more than 60 years
Evidence of alcohol or drug abuse
Evidence of unstable forms of psoriasis, including guttate, erthrodermic, exfoliative or pustular psoriasis.
Psoriasis area and severity index of more than 20
patients suffering from any critical disease of vital organs and chronic diseases like cancer, AIDS,TB etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the psoriasis area and severity index between baseline and end of studyTimepoint: Change in the psoriasis area and severity index between baseline and end of study
- Secondary Outcome Measures
Name Time Method Psoriasis disability index (PDI) at base line and end of studyTimepoint: Time frame at 0 week, 6 week and 12 week